Skip to main content
Year archive

Pharming Group N.V. — 2018 filings

All 18 regulatory filings released by Pharming Group N.V. (PHARM) in 2018, sourced directly from the official regulator.

18 Filings
2018 Period
2018 filings (18)
Filing Released Lang
Pharming reports favourable conclusion from first investigator-initiated direct comparative real-world study of acute hereditary angioedema therapies
Regulatory Filings
2018-12-07 English
Pharming Group reports interim financial results for the first nine months of 2018
Interim / Quarterly Report 9M 2018
2018-10-25 English
Pharming reports positive data from first
Earnings Release Q4 2018
2018-10-17 English
Pharming Receives Complete Response Letter from FDA
Legal Proceedings Report
2018-09-19 English
Pharming announces further issue of shares as employee options are exercised
Share Issue/Capital Change
2018-07-30 English
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-07-26 English
Pharming Reports on Financial Results for the First Half of 2018
Interim / Quarterly Report H1 2018
2018-07-26 English
Pharming announces Agenda for its Capital Markets Briefing to be held on 21 June 2018 in New York
Regulatory Filings
2018-06-05 English
Pharming Reports on Annual General Meeting of Shareholders
AGM Information
2018-05-24 English
Pharming Group Interim Report on Financial Results for the First Quarter 2018
Interim / Quarterly Report Q1 2018
2018-05-17 English
A global awareness day for a rare life-threatening condition: World HAEday, 16th May 2018
Regulatory Filings
2018-05-16 English
Pharming announces publication of 2017 Annual Report and invitation to Annual General Meeting of Shareholders
Report Publication Announcement
2018-04-11 English
Annual Report 2017
Annual Report FY 2017
2018-03-29 English
Pharming enters the Euronext Amsterdam SmallCap-index (AScX)
Regulatory Filings
2018-03-15 English
Pharming announces issue of shares as majority of remaining warrants are exercised
Share Issue/Capital Change
2018-03-12 English
Pharming Group Report on Preliminary Financial Results for 2017
Earnings Release FY 2017
2018-03-07 English
Pharming announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST(r) for Prophylaxis of Hereditary Angioedema Attacks
Regulatory Filings
2018-01-17 English
Pharming announces further conversion of its Ordinary Convertible Bonds
Capital/Financing Update
2018-01-04 English